BridgeBio Pharma Expands Investor Base, Raising An Additional $135 Million, And Discloses Genetic Disease Pipeline Programs

Wednesday, September 13, 2017 1 min read

Key Takeaway: BridgeBio Pharma Expands Investor Base, Raising An Additional $135 Million, And Discloses Genetic Disease Pipeline Programs

Full Press Release Details

BridgeBio Pharma Expands Investor Base, Raising An Additional $135 Million, And Discloses Genetic Disease Pipeline Programs.